Search for a command to run...
After serving as Chief Legal Officer and then CFO at Salesforce, Amy Weaver became CEO of Direct Relief, a global humanitarian organization that provides medical aid to people impacted by poverty, disasters, and civil conflict around the world.
An interview with Lada Nuzhna, founder of General Control, exploring her journey in biotech, the challenges of developing aging therapies, and her mission to engineer epigenetic medicines that could potentially extend human lifespan.
In this episode, Sajith Wickramasekara, CEO of Benchling, discusses how AI can accelerate drug discovery, reduce development costs, and transform the biotech industry by making scientific research more efficient and data-driven.
Dave Ricks, CEO of Eli Lilly, discusses the company's groundbreaking GLP-1 drugs, their potential beyond weight loss, the complexities of drug development and pricing, and how Eli Lilly is innovating in pharmaceutical research and direct-to-consumer healthcare.
Ken Langone shares his remarkable journey from a poor kid to a successful businessman, highlighting the power of loyalty, integrity, and the American Dream through his experiences co-founding Home Depot and investing for the long term.
A deep dive into the potential of virtual cell models and AI to accelerate scientific discovery, drug development, and biological understanding by creating more predictive and efficient research tools.
Here's a two-sentence description for the episode: In this episode of Prof G Markets, Donald Trump attempts to fire Federal Reserve Governor Lisa Cook over unproven allegations of mortgage fraud, raising concerns about the independence of the Federal Reserve. The podcast also discusses Eli Lilly's promising new oral obesity drug and explores strategies for young professionals to remain employable in the age of artificial intelligence.